Contact your practitioner
There was a problem completing your request.
Contact your practitioner directly about scheduling.
Geography should never be a barrier to exceptional endocrinology care. Whether we hold a full license in your state or not, there is a meaningful path to working together — and we will never turn a patient away simply because of where they live.
Hover over any state marker to see its current licensing status.
Patients located in New Jersey receive the full scope of endocrinology care — including comprehensive evaluation, laboratory and imaging orders, diagnosis, treatment planning, prescription management, and ongoing follow-up — all delivered via telehealth from the comfort of home.
We are actively pursuing licensure in Delaware, Maryland, Connecticut, Pennsylvania, Virginia, North Carolina, and Ohio. Once approved in each state, patients will have access to the full scope of telehealth endocrinology care available in New Jersey — including lab orders, prescriptions, and comprehensive follow-up. In the meantime, patients in these states are welcome to engage through our consultative services described below.
Want to be notified the moment we are approved?
Use the notification form below to receive an email as soon as full prescriptive care becomes available in your state.
Florida, Texas, and California are major expansion targets on our roadmap, with licensure expected within approximately six months. These states represent a substantial portion of our prospective patient base, and reaching them is a top priority. Patients in these states are welcome to engage through our consultative services in the interim.
Florida
Coming in ~6 months
Texas
Coming in ~6 months
California
Coming in ~6 months
For patients in states where we are not yet licensed, we provide formal physician consultation — the same model used when a specialist is consulted by a local practice, a hospital, or a primary care physician anywhere in the country.
After a comprehensive telehealth consultation, we prepare detailed written consultation letters addressed to both the patient and their primary care physician (PCP). These letters outline our clinical findings, recommended laboratory tests, imaging studies, and — where appropriate — specific medication recommendations that the patient's local clinician can act upon.
Your local physician retains prescriptive authority and ordering responsibility in their state, but they receive the full benefit of board-certified endocrinology expertise guiding every decision. This is standard, well-established medical practice — and it ensures that no patient is excluded from specialized endocrinology care simply because of where they live.
You do not need a referral to request a consultation. Patients may reach out directly. We will coordinate with your local clinician on your behalf and ensure they have everything needed to implement our recommendations.
For patients outside our licensed states, here is exactly what to expect from start to finish.
Book a telehealth appointment directly through our website — no referral required. Let us know your state of residence so we can prepare accordingly.
You meet one-on-one with Dr. DeLuzio for a thorough review of your history, symptoms, prior labs, medications, and goals. This is a full clinical consultation — not a brief intake.
Following your visit, detailed consultation letters are prepared — one addressed to you and one to your primary care physician. These letters document clinical findings and provide specific, actionable recommendations.
Your PCP receives a professional consultation letter outlining recommended labs, imaging, and medications. They can act on these recommendations within their own practice, just as they would with any specialist consultation.
As results come in and your care evolves, follow-up consultations are available to review findings, adjust recommendations, and continue guiding your treatment plan in collaboration with your local team.
Canadian patients are welcome to engage through the same consultative model available to patients in unlicensed US states. After your telehealth consultation, we prepare formal consultation letters addressed to you and your Canadian physician (GP or specialist), who can then order labs, imaging, and prescribe medications based on our expert recommendations.
These letters outline our clinical findings, recommended laboratory tests, imaging studies, and — where appropriate — specific medication recommendations that your local Canadian physician can act upon. Your physician retains all prescriptive and ordering authority within Canada, but receives the full benefit of board-certified US endocrinology expertise guiding every decision.
No US prescription authority is involved — this is purely expert guidance routed through your local provider. This is the same model used when any specialist is consulted by a local practice, and it ensures that geography never becomes a barrier to exceptional endocrinology care.
Same pricing, same quality. Canadian patients pay the same visit fees as US patients: $300 for initial consultations (60 minutes) and $150 for follow-ups (30 minutes). You receive the same level of expert endocrinology evaluation and guidance regardless of geography.
We are actively pursuing licensure in additional states. Enter your email and state below and we will notify you the moment full prescriptive care becomes available in your area.
Absolutely. Patients in unlicensed states can engage through our formal consultative services. You will receive a comprehensive telehealth consultation and detailed written recommendations — addressed to both you and your primary care physician — covering labs, imaging, and medications. Your local clinician can then act on those recommendations within their own practice. This is the same model used when any specialist is consulted by a local practice.
In states where we are fully licensed, we can directly order labs and imaging, prescribe medications, and manage your care end-to-end. In states where we are not yet licensed, we provide expert clinical guidance through formal consultation letters — your local physician retains prescriptive and ordering authority, but they receive the full benefit of board-certified endocrinology expertise directing every recommendation.
No referral is needed. You may contact us directly to schedule a consultation regardless of your state. We will coordinate with your local clinician on your behalf and ensure they receive everything they need to implement our recommendations.
Yes. Canadian patients are welcome to engage through the same consultative model available to patients in unlicensed US states. After your telehealth consultation, we prepare formal consultation letters addressed to you and your Canadian physician (GP or specialist), who can then order labs, imaging, and prescribe medications based on our expert recommendations. No US prescription authority is involved — purely expert guidance routed through your local provider.
Physicians must hold an active license in the state where the patient is physically located at the time of a telehealth visit. This is a federal and state regulatory requirement. Full prescriptive care — including ordering labs, imaging, and medications — requires that license. Consultative services, however, follow a different model and allow us to serve patients in any state.
Our goal is to hold active licenses in 15 to 20 of the most important states over the coming years, with a focus on states with the highest patient demand. We are currently licensed in New Jersey, actively pursuing licensure in Delaware, Maryland, Connecticut, Pennsylvania, Virginia, North Carolina, and Ohio (coming soon), and targeting Florida, Texas, and California within approximately six months.